Financier | Commitments |
---|---|
IDA Credit | 35.00 |
P165425
Closed
Steen Byskov , Philip M. Schuler, Marlon Rawlins
The Co-operative Republic of Guyana
March 27, 2018
(as of board presentation)
June 22, 2018
August 22, 2018
US$ 25.00 million
Ministry of Finance,Bank of Guyana
2018
US$ 35.00 million
N/A
Not Applicable
June 30, 2019
BANK APPROVED
June 29, 2021
Financier | Commitments |
---|---|
IDA Credit | 35.00 |
Product Line | IBRD/IDA |
---|---|
IBRD Commitment | N/A |
IDA Commitment | 35.00 |
IBRD + IDA Commitment | 35.00 |
Lending Instrument | |
---|---|
Grant Amount | N/A |
Total Project Cost** | 25.00 |
Period | Financier | Transaction Type | Amount (US$) |
---|---|---|---|
Feb 15, 2020 | IDA-62860 | Int Charges | 124,305.54 |
Aug 15, 2024 | IDA-62860 | Int Charges | 1,644.25 |
Aug 15, 2024 | IDA-62860 | Int Charges | 1,644.25 |
Feb 15, 2024 | IDA-62860 | Int Charges | 120,828.39 |
Feb 15, 2024 | IDA-62860 | Int Charges | 120,828.39 |
Feb 15, 2024 | IDA-62860 | Int Charges | 209.64 |
Feb 15, 2024 | IDA-62860 | Int Charges | 209.64 |
Jun 22, 2018 | IDA-62860 | Loan Commitment | 35,000,000.00 |
Aug 15, 2023 | IDA-62860 | Int Charges | 121,910.03 |
Aug 15, 2023 | IDA-62860 | Int Charges | 121,910.03 |
Aug 15, 2023 | IDA-62860 | Int Charges | 598.89 |
Aug 15, 2023 | IDA-62860 | Int Charges | 598.89 |
Feb 15, 2023 | IDA-62860 | Int Charges | 120,720.06 |
Feb 15, 2023 | IDA-62860 | Int Charges | 120,720.06 |
Feb 15, 2023 | IDA-62860 | Int Charges | 1,049.05 |
Feb 15, 2023 | IDA-62860 | Int Charges | 1,049.05 |
Aug 15, 2022 | IDA-62860 | Int Charges | 370.86 |
Aug 15, 2022 | IDA-62860 | Int Charges | 370.86 |
Aug 15, 2022 | IDA-62860 | Int Charges | 120,815.69 |
Aug 15, 2022 | IDA-62860 | Int Charges | 120,815.69 |
Feb 15, 2022 | IDA-62860 | Int Charges | 126,058.01 |
Feb 15, 2022 | IDA-62860 | Int Charges | 126,058.01 |
Feb 15, 2022 | IDA-62860 | Int Charges | 1,725.40 |
Feb 15, 2022 | IDA-62860 | Int Charges | 1,725.40 |
Aug 15, 2021 | IDA-62860 | Int Charges | 255.24 |
Aug 15, 2021 | IDA-62860 | Int Charges | 255.24 |
Aug 15, 2021 | IDA-62860 | Int Charges | 129,962.03 |
Aug 15, 2021 | IDA-62860 | Int Charges | 129,962.03 |
Feb 15, 2021 | IDA-62860 | Int Charges | 2,836.36 |
Feb 15, 2021 | IDA-62860 | Int Charges | 2,836.36 |
Feb 15, 2021 | IDA-62860 | Int Charges | 131,569.72 |
Feb 15, 2021 | IDA-62860 | Int Charges | 131,569.72 |
Aug 15, 2020 | IDA-62860 | Int Charges | 1,517.07 |
Aug 15, 2020 | IDA-62860 | Int Charges | 1,517.07 |
Aug 15, 2020 | IDA-62860 | Int Charges | 124,693.46 |
Aug 15, 2020 | IDA-62860 | Int Charges | 124,693.46 |
Feb 15, 2019 | IDA-62860 | Int Charges | 102,344.05 |
Feb 15, 2019 | IDA-62860 | Int Charges | 102,344.05 |
Sep 19, 2018 | IDA-62860 | Loan Disb | 34,214,168.00 |
Aug 15, 2019 | IDA-62860 | Int Charges | 557.62 |
Aug 15, 2019 | IDA-62860 | Int Charges | 557.62 |
Aug 15, 2019 | IDA-62860 | Int Charges | 125,756.69 |
Aug 15, 2019 | IDA-62860 | Int Charges | 125,756.69 |
Feb 15, 2020 | IDA-62860 | Int Charges | 821.63 |
Feb 15, 2020 | IDA-62860 | Int Charges | 821.63 |
Feb 15, 2020 | IDA-62860 | Int Charges | 124,305.54 |
Aug 15, 2024 | IDA-62860 | Int Charges | 118,918.00 |
Aug 15, 2024 | IDA-62860 | Int Charges | 118,918.00 |
Name | Review | Date |
---|---|---|
Progress towards achievement of PDO | Moderately Satisfactory | 2019-06-28 |
Program Management | Satisfactory | 2019-06-28 |
Overall Implementation Progress (IP) | Moderately Satisfactory | 2019-06-28 |
Monitoring and Evaluation | Satisfactory | 2019-06-28 |
INDICATOR | IMPLEMENTATION COMPLETION & RESULTS REPORT: 06-30-2021 |
---|---|
Outcomes | Moderately Satisfactory |
Risk to Development Outcome | |
Bank Performance | Substantial |
Borrower Performance | |
Government Performance | |
Implementing Agency |
INDICATOR | ICR REVIEW: 01-19-2022 | PROJECT PERFORMANCE ASSESSMENT REPORT: |
---|---|---|
Outcome Rating | Moderately Satisfactory | N/a |
Risk To Development Outcome | N/a | |
Bank Performance | Satisfactory | N/a |
Borrower Performance | N/a | |
Government Performance | Not Rated | N/a |
Implementing Agency | N/a | |
Icr Quality | Substantial | N/a |
M&e Quality | N/a |